Source: WIRED
Jersey's regulatory autonomy as a Crown Dependency has created a vacuum that licensed producers and exporters have rushed to fill, turning a tax haven's governance structure into an infrastructure advantage for the European medical cannabis market. The island now hosts major suppliers serving Germany, Italy, and other EU markets at scale—a position that emerged not from intentional industrial policy but from the gap between UK drug scheduling and Jersey's ability to set its own rules. This reshuffles both geopolitics (small jurisdictions leveraging sovereignty for high-value sectors) and the legitimacy calculus of cannabis, where European medical legitimacy now flows through a British island most people couldn't locate on a map.